Invention Grant
- Patent Title: Use of ciclopirox as a modulator of the heme group biosynthesis and in the treatment of porphyrias and other diseases
-
Application No.: US16614873Application Date: 2018-04-27
-
Publication No.: US11337966B2Publication Date: 2022-05-24
- Inventor: Oscar Millet Aguilar-Galindo , Arantza Sanz Parra , Ana Laín Torre , Pedro David Urquiza Ortiz , Juan Manuel Falcón Pérez , Joaquín Castilla Castrillón , Itxaso San Juan Quintana , Ganeko Bernardo-Seisdedos
- Applicant: ASOCIACIÓN CENTRO DE INVESTIGACIÓN COOPERATIVA EN BIOCIENCIAS-CIC bioGUNE
- Applicant Address: ES Derio-Vizcaya
- Assignee: ASOCIACIÓN CENTRO DE INVESTIGACIÓN COOPERATIVA EN BIOCIENCIAS-CIC bioGUNE
- Current Assignee: ASOCIACIÓN CENTRO DE INVESTIGACIÓN COOPERATIVA EN BIOCIENCIAS-CIC bioGUNE
- Current Assignee Address: ES Derio-Vizcaya
- Agency: Hultquist, PLLC
- Agent Steven J. Hultquist
- Priority: EP17382371 20170619
- International Application: PCT/EP2018/060847 WO 20180427
- International Announcement: WO2018/233914 WO 20181227
- Main IPC: A61K31/4418
- IPC: A61K31/4418 ; A61P7/00 ; A61K9/00 ; A61K9/06
Abstract:
The present invention relates to the use of the compound ciclopirox or a pharmaceutically acceptable salt or solvate thereof for the treatment and/or prevention of a disease caused by dysregulated heme group biosynthesis, with the proviso that said disease is not congenital erythropoietic porphyria.
Public/Granted literature
Information query
IPC分类:
